Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: old-fashioned (3), old (260), square (21)

Carboplatin(AUC5)-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL 21 day Regimen • Ovary-Carboplatin (AUC5)-Paclitaxel (21 day) Indication • First line postoperative or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Paclitaxel21day.pdf

Capecitabine-Streptozocin

Description: Chemotherapy Protocol NEUROENDOCRINE CAPECITABINE-STREPTOZOCIN Regimen • Neuroendocrine – Capecitabine-Streptozocin Indication • Metastatic or locally advance neuroendocrine tumours irrespective of primary site, predominantly
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Capecitabine-Streptozocin.pdf

Dr Kristin Veighey, associate director and academic career development lead for medical clinical research fellows

Description: Southampton Academy of Research Auto Generated Title Dr Veighey aims to identify and promote research training opportunities for current and future
Url: /ClinicalResearchinSouthampton/Our-people/Education-and-training-people/Dr-Kristin-Veighey-associate-director-and-academic-career-development-lead-for-medical-clinical-research-fellows.aspx

COV001_PIS_v5.0_21_Apr_2020_localised

Description: Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Wing, Mailpoint 218 Southampton SO16 6YD Te
Url: /Media/Southampton-Clinical-Research/COVID-19/Vaccine-trial/COV001-PIS-v5.0-21-Apr-2020-localised.docx

Information for investigators

Description: Expressions of Interest (EOI) We are aware that you may still be receiving EOIs for new studies. Currently we are only
Url: /Media/Southampton-Clinical-Research/COVID-19/info-for-researchers-and-sponsors/Information-for-investigators.pdf

Word document

Description: Word Specification Sample Working Draft 04, 16 August 2002 Document identifier: wd-spectools-word-sample-04 Location: http://www.oasis-ope
Url: /Media/UHS-website-2019/Docs/Zengenti-Mock/Word-document.doc

UHS support timeline for fellowships

Description: UHS personal fellowship submissions Guidance on where to start, timelines and finding support ? Pre-submission preparations ?decide which scheme is suitable
Url: /Media/Southampton-Clinical-Research/Grants/Download/UHS-support-timeline-for-fellowships.pdf

PRIVACY NOTICE_Synergy between PCI with TAXUS and Cardiac SurgeryREV - FINAL

Description: Synergy between PCI with TAXUS and Cardiac Surgery: SYNTAX Extended Survival (SYNTAXES) This is a privacy notice for patients who took
Url: /Media/Southampton-Clinical-Research/News-stories/PRIVACY-NOTICE-Synergy-between-PCI-with-TAXUS-and-Cardiac-SurgeryREV-FINAL.docx

ICA Internship - Checklist 2018 2019

Description: 4 CAC Awards 2018/9 Appendix 1: Internship Award – Checklist Name: Area of clinical academic :interest:: Contact details: E: T: Criteria
Url: /Media/Southampton-Clinical-Research/ICA-Internship-Checklist-2018-2019.docx

Southampton experts use innovative device to prevent sight loss in young patients

Description: Southampton experts use innovative device to prevent sight loss in young patients
Url: /AboutTheTrust/Newsandpublications/Latestnews/2017/June-2017/Southampton-experts-use-innovative-device-to-prevent-sight-loss-in-young-patients.aspx

441 to 450 of 1000

Previous … 43 44 45 46 47 … Next